Bay City Capital Fund V Co-Investment Fund LP

10% owner at Viracta Therapeutics, Inc. · on record since Apr 7, 2009
10% owner at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
10% owner at Epizyme, Inc. · on record since May 30, 2013
10% owner at INTERLOTT TECHNOLOGIES INC · on record since May 21, 2013
10% owner at Dermira, Inc. · on record since Oct 8, 2014
10% owner at Enliven Therapeutics, Inc. · on record since Mar 16, 2020

Insider trading activity of Bay City Capital Fund V Co-Investment Fund LP

Transactions on record: 56; since Jul 1, 2010

Open-market buys: 6; $14.2M

Open-market sells: 6; $15.8M

Companies traded: 4; last filing Mar 16, 2020

Figures computed from official regulatory filings — .

Companies where Bay City Capital Fund V Co-Investment Fund LP has traded

Enliven Therapeutics, Inc.9 tx · Mar 16, 2020
Epizyme, Inc.11 tx · $21.1M · Jan 12, 2016
Viracta Therapeutics, Inc.18 tx · $13.3M · Jul 28, 2015
HYPERION THERAPEUTICS INC18 tx · $6.7M · Oct 21, 2013

Track record of Bay City Capital Fund V Co-Investment Fund LP

Open-market buys: 6

Last buy: Jan 12, 2016

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Bay City Capital Fund V Co-Investment Fund LP

Co-insiders of Bay City Capital Fund V Co-Investment Fund LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-16,103	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	690,232	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-5,372	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-281,878	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-845,008	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	AwardD (derivative)	15,457	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-3,220,915	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	13,148	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-61,378	—	n/a (No price was disclosed in the filing)		SEC
Epizyme, Inc.Listing unverified	Jan 12, 2016	Buy	10,389	9.00 USD	$93.5K	conv 37ClusterFirst in 12mo	SEC
Epizyme, Inc.Listing unverified	Jan 12, 2016	Buy	545,166	9.00 USD	$4.9M	conv 50ClusterFirst in 12mo	SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-3,962	3.46 USD	$13.7K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	20,766	1.32 USD	$27.4K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-1,089,788	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-207,938	3.46 USD	$719.5K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	1,089,788	1.32 USD	$1.4M		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-10,383	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-20,766	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	10,383	1.32 USD	$13.7K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-7,925	3.46 USD	$27.4K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-415,877	3.46 USD	$1.4M		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	544,893	1.32 USD	$719.3K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-544,893	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Epizyme, Inc.Listing unverified	Feb 12, 2014	Sell	-457,940	29.25 USD	$13.4M		SEC
Epizyme, Inc.Listing unverified	Feb 12, 2014	Sell	-8,727	29.25 USD	$255.3K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-16,103	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	690,232	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-5,372	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-281,878	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-845,008	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	AwardD (derivative)	15,457	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-3,220,915	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	Other	13,148	—	n/a (No price was disclosed in the filing)		SEC
Enliven Therapeutics, Inc.Listing on record	Mar 16, 2020	OtherD (derivative)	-61,378	—	n/a (No price was disclosed in the filing)		SEC
Epizyme, Inc.Listing unverified	Jan 12, 2016	Buy	10,389	9.00 USD	$93.5K	conv 37ClusterFirst in 12mo	SEC
Epizyme, Inc.Listing unverified	Jan 12, 2016	Buy	545,166	9.00 USD	$4.9M	conv 50ClusterFirst in 12mo	SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-3,962	3.46 USD	$13.7K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	20,766	1.32 USD	$27.4K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-1,089,788	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-207,938	3.46 USD	$719.5K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	1,089,788	1.32 USD	$1.4M		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-10,383	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-20,766	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	10,383	1.32 USD	$13.7K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-7,925	3.46 USD	$27.4K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Sell	-415,877	3.46 USD	$1.4M		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	Other	544,893	1.32 USD	$719.3K		SEC
Viracta Therapeutics, Inc.Listing unverified	Jul 28, 2015	OtherD (derivative)	-544,893	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Epizyme, Inc.Listing unverified	Feb 12, 2014	Sell	-457,940	29.25 USD	$13.4M		SEC
Epizyme, Inc.Listing unverified	Feb 12, 2014	Sell	-8,727	29.25 USD	$255.3K		SEC